GnRh Agonist Treatment Improves Implantation and Pregnancy Rates of Frozen–Thawed Embryos Transfer

Journal of Obstetrics and Gynecology of India

Volumn 67, Issue 2, 2017, Pages 133-136

  Hebisha, S A ^a   Adel, H M ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

FET; GnRH agonist; ICSI; Vitrification

Indexed keywords

ESTRADIOL VALERATE; PROGESTERONE; TRIPTORELIN;

ADULT; ARTICLE; DRUG DOSE REDUCTION; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FREEZE THAWING; HORMONAL THERAPY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84984918830     PISSN: 09719202     EISSN: 09756434     Source Type: Journal    
DOI: 10.1007/s13224-016-0936-5     Document Type: Article

References (16)

1. Skovmand K. Blastocyst frozen embryo transfer (FET): comparison of outcome with replacement in natural or programmed/medicated cycle. Fertil Steril. 2004;82:s154.
2. Ghobara T, Vandekerckhove P. Cycle regimens for frozen–thawed embryo transfer. Cochrane Database Syst Rev. 2008;(1):CD003414. doi:10.1002/14651858.CD003414.pub2.
3. Cohen J, DeVane GW, Elsner CW, et al. Cryopreserved zygotes and embryos and endocrinologic factors in the replacement cycle. Fertil Steril. 1988;50:61–7.
4. Muasher SJ, Kruithoff C, Simonetti S, et al. Controlled preparation of the endometrium with exogenous steroids for the transfer of frozen-thawed pre-embryos in patients with anovulatory or irregular cycles. Hum Reprod. 1991;6:443–5.
5. Gelbaya TA, Nardo LG, Hunter HR, et al. Cryopreserved thawed embryo transfer in natural cycle or down-regulated hormonally controlled cycles: a retrospective study. Fertil Steril. 2006;85:603–9.
6. Andersen AG, Als-Nielsen B, Hornnes PJ, et al. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod. 1995;10:3202–5.
7. Nawroth F, Ludwig M. What is the ‘ideal’ duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols? Hum Reprod. 2005;20:1127–34.
8. Dor J, Rudak E, Davidson A, et al. Endocrine and biological factors influencing implantation of human embryos following cryopreservation. Gynecol Endocrinol. 1991;5:203–11.
9. El Toukhy T, Taylor A, Khalaf Y, et al. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study. Hum Reprod. 2004;19:874–9.
10. Queenan JT Jr, Veeck LL, Seltman HJ, et al. Transfer cryopreserved-thawed pre-embryos in a natural cycle or a programmed cycle with exogenous hormonal replacement yields similar pregnancy results. Fertil Steril. 1994;62:545–50.
11. Lelaidier C, de Ziegler D, Gaetano J, et al. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist. Hum Reprod. 1992;7:1353–6.
12. Oehninger S, Mayer J, Muasher S. Impact of different clinical variables on pregnancy outcome following embryo cryopreservation. Mol Cell Endocrinol. 2000;169:73–7.
13. Lotradi KE, Kolibiankis EM, Venetis CA, et al. Cryopreservation of human embryos by vitrification or slow freezing: a systemic review and meta-analysis. Fertil Steril. 2008;90:186–93.
14. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the cryotop method. Theriogenology. 2007;67:73–80.
15. Glujovsky D, Pesce R, Fiszbajn G, et al. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev. 2010;20:CD006359.
16. Yang X, Dong X, Huang K, et al. The effect of accompanying dominant follicle development/ovulation on the outcomes of frozen-thawed blastocyst transfer in HRT cycle. Int J Clin Exp Pathol. 2013;6:718–23.